Imagine your brain and gut having a phone line connecting them, constantly chatting and exchanging information about your health. This is what scientists call the gut-brain axis (GBA). In recent years, researchers have discovered that our gut microbiota (GM), the microorganisms living in our digestive system, can play a role in the development of Parkinson’s disease (PD). They have even found that certain therapies for PD, like deep brain stimulation and levodopa-carbidopa intestinal gel infusion, can potentially influence the composition of GM. However, there is still much to learn about how different treatments affect GM and how it contributes to an individual’s response to medication. Future studies with controlled trials will help us understand this intricate relationship better and explore GM-targeted treatments for PD. If you want to dive into the fascinating world of the gut-brain axis and its connection to Parkinson’s disease, check out the full research article!
The Institute for the Future of Human Potential
☰
